Autolus Therapeutics (AUTL) Exchange Rate Effect (2018 - 2025)
Autolus Therapeutics' (AUTL) quarterly Exchange Rate Effect came in at $589000.0 in Q4 2025, up 101.54% YoY from $292247.9 in Q4 2024, and up 116.44% on a QoQ basis from -$3.6 million in Q3 2025.
Analysis
Autolus Therapeutics (AUTL) Exchange Rate Effect (2018 - 2025) Analysis & Trends
Autolus Therapeutics (AUTL) has 8 years of Exchange Rate Effect data on file, last reported at $589000.0 in Q4 2025.
- Quarterly Exchange Rate Effect rose 101.54% year-over-year to $589000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6.3 million (up 2505.75% YoY) and the FY2025 annual result came in at $6.3 million, up 2505.75% from the prior year.
- Exchange Rate Effect climbed to $589000.0 in Q4 2025, from -$3.6 million in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $37.7 million in Q3 2024 to a low of -$38.2 million in Q4 2024.
- A 5-year average of -$404100.0 and a median of $1.0 million in 2021 frame the typical range for Exchange Rate Effect.
- The widest YoY moves for Exchange Rate Effect: up 1409.95% in 2022, down 1502.55% in 2022.
- Tracing AUTL's Exchange Rate Effect over 5 years: stood at $734000.0 in 2021, then surged by 1409.95% to $11.1 million in 2022, then slipped by 11.82% to $9.8 million in 2023, then sank by 491.04% to -$38.2 million in 2024, then soared by 101.54% to $589000.0 in 2025.
- The last three Exchange Rate Effect figures came in at $589000.0 (Q4 2025), -$3.6 million (Q3 2025), and $5.7 million (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -2.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 19.84 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -2.45 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -287,000.00 |
| 10 | Autolus Therapeutics | 594.86 Mn | 393.23 Mn | 25.22 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 589,000.00 |
| Sep 30, 2025 | -3.58 Mn |
| Jun 30, 2025 | 5.72 Mn |
| Mar 31, 2025 | 3.56 Mn |
| Dec 31, 2024 | -38.22 Mn |
| Sep 30, 2024 | 37.72 Mn |
| Jun 30, 2024 | 1.42 Mn |
| Mar 31, 2024 | -1.19 Mn |
| Dec 31, 2023 | 9.77 Mn |
| Sep 30, 2023 | -9.30 Mn |
| Jun 30, 2023 | 7.23 Mn |
| Mar 31, 2023 | 7.33 Mn |
| Dec 31, 2022 | 11.08 Mn |
| Sep 30, 2022 | -14.80 Mn |
| Jun 30, 2022 | -18.68 Mn |
| Mar 31, 2022 | -5.98 Mn |
| Dec 31, 2021 | 734,000.00 |
| Sep 30, 2021 | -4.45 Mn |
| Jun 30, 2021 | 1.33 Mn |
| Mar 31, 2021 | 1.63 Mn |